CLDN18 and adenocarcinoma: In normal tissues, the CLDN18.2 epitope within the tissue adhesion complex is completely inaccessible; however, on malignant transformation, cell adhesion is disrupted, and the CLDN18.2 epitope is exposed on the gastric and GEJ (G/GEJ) adenocarcinoma cell surface, making it a promising target [23].